GlassScriptPhysician profile
Tamara L Madjid
NPI 1497908032
$4,633.54
in general payments reported to CMS, 2019-2025
29 companies · $951 in 2025
The $951 reported for 2025 was more than what 96% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,298 · 2022: $732 · 2023: $777 · 2024: $875 · 2025: $951.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,379 · Education: $200 · Travel and Lodging: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,378.65 |
| Education | $199.98 |
| Travel and Lodging | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $949.77 | 2021-2025 | |
| Abbvie INC. | $791.61 | 2021-2025 | |
| Astellas Pharma US INC | $583.19 | 2023-2025 | Veozah, Myrbetriq |
| Daiichi Sankyo INC. | $219.22 | 2021-2022 | |
| Therapeuticsmd, INC. | $207.88 | 2021-2022 | |
| Organon LLC | $190.40 | 2021-2025 | Nexplanon |
| Pfizer INC. | $166.38 | 2021-2025 | |
| Evofem Biosciences, INC. | $165.97 | 2021-2022 | |
| Exeltis, USA INC. | $158.52 | 2021-2025 | Slynd |
| Millicent US INC | $158.31 | 2023-2025 | Femlyv, Intrarosa, Femring |
| Sumitomo Pharma America, INC. | $144.76 | 2023-2025 | Myfembree, Gemtesa |
| Sage Therapeutics, LLC | $144.46 | 2021-2025 | Zurzuvae |
| Lilly USA, LLC | $140.88 | 2024 | Zepbound, Jardiance |
| Hologic Sales and Service, LLC | $132.55 | 2022-2025 | Myosure Tissue Removal Device, Novasure, Fluent Fluid Management System |
| Bayer Healthcare Pharmaceuticals INC. | $114.26 | 2022-2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $52.67 | 2021 | |
| Myovant Sciences INC. | $37.70 | 2022 | |
| Shield Therapeutics INC | $35.77 | 2025 | |
| Merck Sharp & Dohme LLC | $31.27 | 2021 | |
| Minerva Surgical, INC | $29.33 | 2023 | |
| Exact Sciences Corporation | $28.36 | 2023-2025 | Cologuard Collection Kit |
| Intuitive Surgical, INC. | $25.00 | 2023 | Da Vinci Surgical System |
| Davol INC. | $23.45 | 2021 | |
| Conmed Corporation | $20.08 | 2025 | Airseal |
| Boston Scientific Corporation | $17.80 | 2025 | Watchman Flx |
| Avion Pharmaceuticals | $17.34 | 2023 | Balcoltra |
| Medtronic, INC. | $16.97 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $15.49 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamara Madjid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.